| EISAI CO. LTD |
| Japan |
| Gesundheit |
| JP3160400002 / 855526 |
| EII (Frankfurt) |
| FRA:EII, ETR:EII, EII:GR |
| Nikkei225 |
| https://www.eisai.com/ |
|
Eisai Co., Ltd. is a major pharmaceutical company specializing in the research, development, and manufacture of innovative pharmaceuticals. Its primary function is to deliver prescription drugs and therapies aimed at treating neurological disorders, ..
>Volltext.. |
| 7825.36 Mio. EUR |
| 7486.89 Mio. EUR |
| 4467.61 Mio. EUR |
| 467.06 Mio. EUR |
| 236.35 Mio. EUR |
| 0.84 EUR |
| 1277.21 Mio. EUR |
| 1765.61 Mio. EUR |
| 478.44 Mio. EUR |
| 0.82 |
| -9.72% |
| -35.69% |
| 0.46 EUR |
| 3.23% |
| 3.26% |
| 29.09.25 - 0.455808€ 28.03.25 - 0.455808€ >weitere anzeigen... |
| - |
| EISAI |
| 04.04.26 |
|
||||
|
||||
|
||||
|
||||
|